Delivery Order SPE2DB20D1109-SPE2DB25FP82R
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,073.80 to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector units on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which is not subject to a set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.00 fixed-price contract is for the supply of 225 mg/1.5 ml Ajovy autoinjector medication. The contract has a ceiling value of $1,092.00 and an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $1,199.10 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 225 mg/1.5 mL autoinjector doses of the drug Ajovy. The contract has a completion date of May 12, 2025 and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of AJOVY 225 mg/1.5 mL auto-injector medication, valued at $1,300.58. This is a firm fixed-price delivery order with no set-aside designation, executed competitively under the company's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,597.47 to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 ml auto-injector units, with an ultimate completion date of September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AJOVY (eptinezumab) 225 mg/1.5 mL auto-injector units valued at $1,187.64. This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the Place of Performance located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,092.00 to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector pens on September 24, 2025, with completion scheduled for September 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,072.34 firm fixed price delivery order is for the supply of Ajovy 225 mg/1.5 ml autoinjector medication. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2020. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a $1,943.71 firm fixed price delivery order to AmerisourceBergen Drug Corp for AJOVY (fremanezumab) 225 mg/1.5 mL syringes on September 26, 2025, with completion targeted for September 29, 2025. This non-set-aside award represents a pediatric migraine prevention medication delivery to support federal medical supply requirements. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ajovy 225 mg/1.5 ml autoinjector medication. The contract has a firm fixed price of $1,053.76 and a performance period ending on August 2, 2024. It is not a set-aside contract. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts by the DLA and other agencies for providing a wide range of...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP82RDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,092.00 to AmerisourceBergen Drug Corp for the supply of Ajovy 225 mg/1.5 mL auto-injector pens. The contract, which was competitively awarded without set-aside designation, was finalized on September 24, 2025, with an ultimate completion date of September 25, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency encompasses a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. This specific delivery order for Ajovy, a migraine treatment medication, demonstrates the company's role in supplying specialized pharmaceutical commodities to support defense healthcare programs. The firm fixed-price arrangement reflects the standardized procurement approach used for pharmaceutical delivery orders under the DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/24/25 |